DANIELA ARRIAGADA: Open Payments
NPI 1669153862 · CLIFTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,008 in 63 payments from 12 companies in 2025. Trend: 2023 $43 · 2024 $254 · 2025 $1,008
Food & beverage: $1,008
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $197 |
| PFIZER INC. | 14 | $189 |
| ABBVIE INC. | 12 | $179 |
| Corcept Therapeutics | 4 | $90 |
| Novo Nordisk Inc | 5 | $86 |
| Bausch Health US, LLC | 4 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| KYOWA KIRIN, INC. | 2 | $36 |
| BioCryst US Sales Co., LLC | 2 | $36 |
| Amgen Inc. | 2 | $33 |
Products named: BREZTRI, NURTEC ODT, VRAYLAR, Korlym, WELLBUTRIN, UBRELVY, Wegovy, ELIQUIS.
Industry payments across NJ — which companies pay providers there.
